- ALS CNTF Treatment Study Group. A double-blind, placebo-controlled trial of subcutaneous recombinant human ciliary neurotrophic factor in ALS. Neurology 1996;46:1244-1249.
- Bensimon G, Lacomblez L, Meininger V, the Riluzole Study Group. A controlled trial of riluzole in ALS. New Eng J Med 1994;330:585-591.
- Bromberg MB, Forshew DA, Nau KL, et al. Motor unit number estimation, isometric strength and EMG measures in ALS. Muscle Nerve 1993;16:1213-1219.
- Buckley J, Warlow C, Smith P et al. Motor neuron disease in England and Wales, 1959-1979. J Neurol Neurosurg Psychiatry. 1983;46:197-205.
- Caroscio JT, Mulvihill MN, Sterling R, Abrams B. ALS: its natural history. Neurol Clin 1987;5:1-8.
- Chaudhuri KR, Crump SJ, Al-Sarraj S et al. The validation of El Escorial criteria for the diagnosis of ALS: a clinico-pathological study. J Neurol Sci 1995;129 (suppl):11-12.
- Dantes M, McComas A. The extent and time course of motorneuron involvement in ALS. Muscle Nerve 1991;14:416-421.
- Gubbay SS, Kahan E, Zilber N et al. ALS a study of its presentation and prognosis. J Neurol Sci 1985;232:295-300.
- Haverkamp LJ, Appel V, Appel SH. Natural history of ALS in a databaase population; validation of a scoring system and a model for survival prediction. Brain 1995;118:707-719.
- Kelly JJ, Thibodeau L, Andres PL, Finison LJ. Use of electrophysiologic tests to measure disease progression in ALS therapeutic trials. Muscle Nerve 1990;13:471-479.
- Kondo K Hemmi I. Clinical statistics in 515 fatal cases of motor neuron disease. Neuroepidemiology 1984;3:129-148.
- Lacomblez L, Bensimon G, Leigh PN et al. A controlled trial of Riluzole in ALS. Lancet 1996;347:1425-1431.
- Li T-M, Alberman EA, Swash M, Comparison of sporadic and familial disease amongst 580 cases of motor neuron disease. J Neurol Neurosurg Psychiatry 1988;51:778-784.
- Li T-M, Swash M, Alberman E. Morbidity and mortality in motor neuron disease; comparison with multiple sclerosis and Parkinson's disease; age and sex -specific rates and cohort analysis. J Neurol Neurosurg Psychiatry 1985;48:320-327.
- McComas AJ. Invited review: motor unit number estimation - methods, results and present status. Muscle Nerve 1991;14:585-597.
- McDonald ER, Wiedenfeld SA, Hillel A, Carpenter CL, Walter RA. Survival in ALS: the role of psychological factors. Arch Neurol 1994;51:17-23.
- Miller RG, Petajan J, Bryan WW et al. A placebo-controlled trial of recombinant human ciliary neurotrophic factor in ALS. Ann Neurol 1996;39:256-260.
- Miller RG, Moore D, Young LA, et al. Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis. Neurology 47:1383-1388.
- Mortara P, Chio A, Rosso MG, Leone M, Shciffer D. Motor neuron disease in the province of Turin Italy 1966-1980: survival analysis in an unselected population.
J Neurol Sci 1984;66:165-173.
- Moss MA, Miller RG, Berchert L, Parry G, Barohn RJ et al. Toward earlier diagnosis of ALS: revised criteria. Neurology 1998;50:768-772.
- Preux P-M, Couratier PH, Boutros-Toni F et al. Survival prediction in sporadic ALS. Neuroepidemiology 1996;15:153-160.
- Ringel SP, Murphy JR, Alderson MK et al. The natural history of ALS. Neurology 1993;43:1316-1322.
- Rosen AD. ALS: clinical features and prognosis. Arch Neurol 1978;35:638-642.
- Schuiz, KF. The Quest for unbiased research: Randomized Clinical Trials and the Consort Reporting Guidelines. Ann Neurol 1997; 41:569-573.
- Stambler N, Charatan M, Cedarbaum JM, ALS CNTF Study Group. Prognostic indicators of survival in ALS. Neurology 1998;50:66-72.
- Swash M, Schwartz MS. A longitudinal study of changes in motor units in motor neuron disease. J Neurol Sci 1982;56:185-197.
- Tandan R, Bradley WG. ALS. 1: clinical features, pathology and ethical issues in management. Ann Neurol 1985;18:271-280.
- Younger DS, Rowland LP, Latov N et al. Lymphoma, motor neuron diseases and amyotrophic lateral sclerosis. Ann Neurol 1991;29:78-86.
- Yuen EC, Olney RK. Longitudinal study of fiber density and motor unit number estimate in patients with ALS. Neurology 1997;49:573-578.
Back to Airlie '98 Contents
